Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDIFAST, INC.

(MED)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medifast : B. Riley Raises Medifast's PT to $400 from $310 After Q1 Results Top Consensus, Keeps Buy Rating

05/05/2021 | 09:18am EDT


© MT Newswires 2021
All news about MEDIFAST, INC.
07/21MEDIFAST, INC. : to Announce Financial Results for the Second Quarter Ended June..
PR
07/07INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Medifast
MT
06/22MEDIFAST : Insider Sale at Medifast (MED) Continues Selling Trend
MT
06/22MEDIFAST : Significant Insider Selling Continues at Medifast (MED)
MT
06/21INSIDER TRENDS : Medifast Insider Extends 90-Day Selling Trend
MT
06/18MEDIFAST : MED) sees Significant Insider Selling Continuing
MT
06/17INSIDER TRENDS : Selling By Insiders Lingers at Medifast
MT
06/16MEDIFAST : Continued Level of Significant Insider Selling at Medifast (MED)
MT
06/15INSIDER TRENDS : Medifast Insider Extends 90-Day Selling Trend
MT
06/03MEDIFAST : Declares Unchanged Quarterly Dividend of $1.42 Per Share, Payable Aug..
MT
More news
Financials (USD)
Sales 2021 1 456 M - -
Net income 2021 163 M - -
Net cash 2021 219 M - -
P/E ratio 2021 20,8x
Yield 2021 1,99%
Capitalization 3 343 M 3 343 M -
EV / Sales 2021 2,15x
EV / Sales 2022 1,90x
Nbr of Employees 713
Free-Float 95,0%
Chart MEDIFAST, INC.
Duration : Period :
Medifast, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIFAST, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 285,51 $
Average target price 360,00 $
Spread / Average Target 26,1%
EPS Revisions
Managers and Directors
Daniel R. Chard Executive Chairman & Chief Executive Officer
James P. Maloney Chief Financial Officer
William Baker Executive Vice President-Information Technology
Kevin G. Byrnes Independent Director
Jeffrey J. Brown Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MEDIFAST, INC.43.40%3 343
BY-HEALTH CO., LTD.13.62%7 220
HERBALIFE NUTRITION LTD.6.01%5 503
BALCHEM CORPORATION17.07%4 375
THE SIMPLY GOOD FOODS COMPANY19.52%3 590
USANA HEALTH SCIENCES, INC.23.57%1 928